Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy

Conditions:   Binge-Eating Disorder;   Obesity Interventions:   Drug: NB medication (Naltrexone Bupropion combination);   Other: Placebo Sponsors:   Yale University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Enrolling by invitation - verified February 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials